Metabolomic analysis of a selective ABCA1 inducer in obesogenic challenge provides a rationale for therapeutic development is a research paper published in EBioMedicine (2021). On theSindex it has a DataRank of 0. It has been cited 31 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01DK104927
National Institutes of Health
Grant: T32AG57468
National Institutes of Health
Grant: UL1TR002003
U.S. Department of Veterans Affairs
Grant: 1I01BX003382
Office of Research and Development
Grant: 20PRE35150022
NIA NIH HHS
Grant: T32 AG057468
BLRD VA
Grant: I01 BX003382
National Institutes of Health
Grant: 5UL1TR002003-08
Clinical and Translational Science Award
National Institutes of Health
Grant: 5R01DK104927-04
The function and regulation of the novel pregnancy-specific hexokinase HKDC1
National Institutes of Health
Grant: 5I01BX003382-04
A Novel Relationship Between the Gut Microbiota and Pancreatic Beta Cells contributes to Gestational Glucose Homeostasis
National Institutes of Health
Grant: 5T32AG057468-02
Training program in the biology and translational research on Alzheimer's disease and related dementias
Health Services Research and Development
National Center for Advancing Translational Sciences
American Heart Association
FWCI
4.86
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Metabolomic analysis of a selective ABCA1 inducer in obesogenic challenge provides a rationale for therapeutic development
Metabolomic analysis of a selective ABCA1 inducer in obesogenic challenge provides a rationale for therapeutic development
Additional file 1 of A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
Additional file 1 of A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
Additional file 4 of A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
Additional file 3 of A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
Additional file 5 of A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
Additional file 5 of A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
Additional file 3 of A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
Additional file 4 of A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
Additional file 2 of A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
Additional file 2 of A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3